✦ LIBER ✦

Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP)

✍ Scribed by S. B. Sutcliffe; P. F. M. Wrigley; A. G. Stansfeld; J. S. Malpas

Book ID: 112286082
Publisher: Springer
Year: 1979
Tongue: English
Weight: 493 KB
Volume: 2
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00258297

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechlorethamine, vinblastine, procarbazi

Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's disease

✍ Margaret J. Harding; Laura J. McNulty; Jim Paul; Fred Lee; Alec Brown; Michael S 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 673 KB

Treatment of advanced Hodgkin's disease

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

✍ John G. Krikorian; Carol S. Portlock; Dr. Saul A. Rosenberg 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views

twenty-seven patients with advanced Hodgkin's disease who failed MOPP (nitrogen mustard, vincristine, procarbazine and prednisone) were treated with adriamycin, bleomycin, vinblastine, and imidazole carboxamide, (ABVD). Complete response (CR) was achieved in 22% of patients and partial response was